Profound Medical Corp
TSX:PRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Profound Medical Corp
Revenue
Profound Medical Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Revenue
$16.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Revenue
CA$1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-4%
|
|
|
MedMira Inc
XTSX:MIR
|
Revenue
CA$188.5k
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-29%
|
|
|
Aurora Spine Corp
XTSX:ASG
|
Revenue
$18m
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Revenue
CA$2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Revenue
$706k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
See Also
What is Profound Medical Corp's Revenue?
Revenue
16.1m
USD
Based on the financial report for Dec 31, 2025, Profound Medical Corp's Revenue amounts to 16.1m USD.
What is Profound Medical Corp's Revenue growth rate?
Revenue CAGR 5Y
17%
Over the last year, the Revenue growth was 51%. The average annual Revenue growth rates for Profound Medical Corp have been 34% over the past three years , 17% over the past five years .
